Overproduction, Purification, and Stability of the Functionally Active Human Carnitine Acetyl Transferase.

Mol Biotechnol

Department of Biology, Ecology and Earth Sciences (DiBEST), Laboratory of Biochemistry, Molecular Biotechnology and Molecular Biology, University of Calabria, Via P. Bucci 4c, 87036, Arcavacata di Rende, Italy.

Published: December 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Human Carnitine Acetyl Transferase (hCAT) reversibly catalyzes the transfer of the acetyl-moiety from acetyl-CoA to L-carnitine, modulating the acetyl-CoA/CoA ratio in mitochondria. Derangement of acetyl-CoA/CoA ratio leads to metabolic alterations that could result in the onset or worsening of pathological states. Due to the importance of CAT as a pharmacological target and to the European directive for reducing animal experimentation, we have pointed out a procedure to produce a recombinant, pure, and functional hCAT using the E. coli expression system. The cDNA encoding for the hCAT was cloned into the pH6EX3 vector. This construct was used to transform the E. coli Rosetta strain. The optimal conditions for the overexpression of the fully active hCAT include induction with a low concentration of IPTG (0.01 mM) and a low growth temperature (25 °C). The recombinant protein was purified from bacterial homogenate by affinity chromatography. The pure hCAT is very stable in an aqueous solution, retaining full activity for at least two months if stored at - 20 °C. These results could be helpful for a broad set of functional studies on hCAT, including drug-design applications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573857PMC
http://dx.doi.org/10.1007/s12033-022-00522-zDOI Listing

Publication Analysis

Top Keywords

human carnitine
8
carnitine acetyl
8
acetyl transferase
8
acetyl-coa/coa ratio
8
hcat
6
overproduction purification
4
purification stability
4
stability functionally
4
functionally active
4
active human
4

Similar Publications

Purpose: We previously identified a dietary pattern (DP) associated with plasma trimethylamine -oxide (TMAO) and choline, the TMAO-DP, where higher scores represent more atherogenic potential of the diet. The mechanisms linking dietary intake to the presence of choline and TMAO in the plasma, and by which TMAO may influence atherosclerosis in humans require further clarification. The objective was to evaluate associations between the TMAO-DP and metabolomic profiles in postmenopausal women from the Women’s Health Initiative (WHI).

View Article and Find Full Text PDF

Background: Acute-on-chronic liver failure (ACLF) is characterized by severe metabolic disturbances; however, the specific metabolomic features and their predictive value on 90-day prognosis remain unclear.

Aim: To identify serum metabolomic changes in patients with ACLF with different prognoses to support clinical prediction of outcomes and treatment decisions.

Methods: This non-interventional, observational case-control study enrolled 58 patients with ACLF.

View Article and Find Full Text PDF

[Mechanisms of puerarin-mediated lipid modulation to enhance glucose-lowering effects via hepatic ChREBP/PPARα/PPARγ in vitro].

Zhongguo Zhong Yao Za Zhi

July 2025

Jiangxi Province Key Laboratory of Traditional Chinese Medicine Etiopathogenisis & Research Center for Differentiation and Development of Traditional Chinese Medicine Basic Theory, Jiangxi University of Chinese Medicine Nanchang 330004, China.

This study aims to investigate the in vitro mechanisms underlying the beneficial effects of puerarin on hepatic insulin resistance(IR) based on the carbohydrate response element-binding protein(ChREBP)/peroxisome proliferator-activated receptor(PPAR)α/PPARγ axis involved in glucose and lipid metabolism. An IR-HepG2 cell model was established by treating cells with dexamethasone for 48 h, and the cells were then treated with 10, 20, and 40 μmol·L~(-1) puerarin for 24 h. Glucose levels and output in the extracellular fluid were measured by the glucose oxidase method, while cell viability was assessed by the cell counting kit-8(CCK-8) assay.

View Article and Find Full Text PDF

Objectives: Multiple acyl-coenzyme A dehydrogenase deficiency (MADD) is a rare, yet treatable, disorder of fatty acid β-oxidation with clinical presentations ranging from neonatal to very-late-onset forms. Very-late-onset MADD often has no identifiable genetic mutations and has been linked to sertraline exposure.

Methods: We report a case of very late-onset MADD with negative genetic testing, potentially associated with sertraline use.

View Article and Find Full Text PDF

APOE genotype influences on the brain metabolome of aging mice - role for mitochondrial energetics in mechanisms of resilience in APOE2 genotype.

Mol Neurodegener

September 2025

Department of Psychiatry and Behavioral Sciences, Duke Institute for Brain Sciences, Department of Medicine, Duke University, Durham, NC, 27708, USA.

Unlabelled: Alzheimer’s disease (AD) risk and progression are significantly influenced by APOE genotype with APOE4 increasing and APOE2 decreasing susceptibility compared to APOE3. While the effect of those genotypes was extensively studied on blood metabolome, less is known about their impact in the brain. Here we investigated the impacts of APOE genotypes and aging on brain metabolic profiles across the lifespan, using human APOE-targeted replacement mice.

View Article and Find Full Text PDF